CureVac N.V. - Laporan Laba Rugi (TTM)

CureVac N.V.
MX ˙ BMV ˙ NL0015436031
Laporan Laba Rugi (TTM)

Laporan Laba Rugi CureVac N.V. menunjukkan perubahan pendapatan dan pengeluaran selama periode waktu tertentu. Data Laporan Laba Rugi meliputi Penjualan dan Pendapatan, Laba Kotor, Penelitian dan Pengembangan (R&D), Beban Penjualan, Umum dan Administrasi (SG&A), Laba Operasi, Beban Pajak Penghasilan, Beban Bunga, Pendapatan Non-Operasi, Laba per Saham (EPS), dan Saham yang Beredar.

Semua angka adalah kelipatan 1,000,000 kecuali unit per saham.

2020
09-30
2020
12-31
2021
03-31
2021
06-30
2021
09-30
2021
12-31
2022
03-31
2022
06-30
2022
09-30
2022
12-31
2023
03-31
2023
06-30
2023
09-30
2023
12-31
2024
03-31
2024
06-30
2024
09-30
2024
12-31
2025
03-31
2025
06-30
Revenue 50 49 56 44 68 103 117 115 97 67 50 38 43 54 59 66 304 535 524 511
Change (%) -1.56 14.14 -21.79 55.42 51.89 13.93 -1.92 -15.75 -30.46 -25.58 -25.05 14.02 25.37 9.75 11.62 360.93 76.30 -2.15 -2.52
% of Revenue 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00
Cost Of Sales 16 14 24 62 175 215 256 242 151 159 142 126 126 116 137 152 139 106 65 26
Change (%) -11.38 72.23 154.83 181.73 22.83 18.81 -5.37 -37.58 5.22 -10.44 -11.82 0.16 -7.58 18.12 10.83 -8.33 -24.26 -38.64 -59.41
% of Revenue 32.21 29.00 43.76 142.58 258.46 209.02 217.97 210.30 155.82 235.79 283.74 333.82 293.25 216.17 232.65 231.00 45.94 19.74 12.38 5.15
Gross Operating Profit 34 35 31 -19 -107 -112 -138 -127 -54 -92 -92 -88 -83 -62 -78 -86 164 430 459 484
Change (%) 3.11 -9.59 -159.22 478.39 4.49 23.28 -8.29 -57.36 69.14 0.71 -4.62 -5.76 -24.63 25.32 10.23 -290.20 161.76 6.83 5.52
% of Revenue 67.79 71.00 56.24 -42.58 -158.46 -109.02 -117.97 -110.30 -55.82 -135.79 -183.74 -233.82 -193.25 -116.17 -132.65 -131.00 54.06 80.26 87.62 94.85
SG&A 56 54 64 81 102 102 105 103 100 107 106 103 95 96 92 85 84 74 72 81
Change (%) -2.81 18.35 26.51 25.98 -0.13 3.03 -2.08 -2.72 6.68 -0.66 -3.59 -7.62 1.07 -4.21 -7.41 -1.37 -11.24 -3.60 13.48
% of Revenue 112.51 111.08 115.18 186.30 151.02 99.30 89.80 89.65 103.51 158.81 211.98 272.65 220.91 178.09 155.43 128.93 27.59 13.89 13.68 15.93
R&D 89 114 208 308 322 816 722 602 566 63 76 95 110 116 119 116 138 153 163 170
Change (%) 28.00 82.67 48.30 4.51 153.23 -11.55 -16.58 -5.97 -88.95 21.53 25.30 15.47 5.22 3.09 -2.53 18.44 11.13 6.38 4.38
% of Revenue 179.10 232.87 372.69 706.67 475.18 792.22 615.09 523.15 583.89 92.78 151.50 253.25 256.48 215.27 202.19 176.55 45.37 28.59 31.09 33.29
OpEx 161 182 297 460 598 1,133 1,083 947 819 292 290 288 296 320 336 341 345 325 295 274
Change (%) 13.44 62.81 54.73 30.12 89.54 -4.45 -12.58 -13.45 -64.37 -0.64 -0.56 2.45 8.24 5.11 1.48 1.10 -5.68 -9.24 -7.35
% of Revenue 323.91 373.27 532.42 1,053.29 881.82 1,100.44 922.89 822.54 844.98 433.00 578.11 766.98 689.20 595.04 569.87 518.12 113.65 60.80 56.39 53.60
Operating Income -111 -134 -241 -416 -530 -1,030 -966 -832 -722 -225 -240 -251 -253 -266 -277 -275 -41 210 228 237
Change (%) 20.14 80.62 72.42 27.46 94.36 -6.29 -13.88 -13.13 -68.92 6.85 4.57 0.72 5.33 4.17 -0.67 -84.95 -606.35 8.86 3.73
% of Revenue -223.91 -273.27 -432.42 -953.29 -781.82 -1,000.44 -822.89 -722.54 -744.98 -333.00 -478.11 -666.98 -589.20 -495.04 -469.87 -418.12 -13.65 39.20 43.61 46.40
Interest Expense -13 -22 -24 -19 -18 -7 -9 -5 -3 -2 -3 -2 -6 -2 -8 -0
Change (%) 69.31 7.40 -18.05 -9.54 -61.40 31.39 -46.13 -29.28 -32.38 18.14 -8.03 141.83 350.85
% of Revenue -26.30 -45.23 -42.56 -44.59 -25.95 -6.60 -7.61 -4.18 -3.51 -3.41 -5.41 -6.64 -14.09 -2.67 -2.61 -0.08
Net Income -107 -129 -219 -361 -468 -412 -313 -219 -122 -249 -291 -301 -302 -260 -273 -278 -77 162 181 194
Change (%) 20.71 69.59 64.74 29.71 -12.01 -23.95 -30.17 -44.12 103.82 17.00 3.37 0.37 -13.94 5.05 1.88 -72.31 -310.34 11.39 7.19
% of Revenue -215.46 -264.21 -392.55 -826.85 -690.10 -399.76 -266.86 -189.98 -126.02 -369.37 -580.67 -800.83 -704.99 -483.96 -463.21 -422.77 -25.40 30.30 34.50 37.93

Source: Capital IQ

Other Listings
IT:1CVAC € 4.58
GB:0A9E
US:CVAC US$ 5.39
DE:5CV € 4.56
AT:CVAC
BG:5CV
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista